Teva Outlines US Opportunities Amid North American Decline

Future Targets Include Generic Symbicort And Alvotech-Partnered Humira Biosimilar

 
• By David Wallace
Target with arrow in bullseye, under magnifying glass
Teva has identified future targets in the US • Source: Shutterstock

More from Strategy

More from Business